Literature DB >> 10720753

Epoxide hydrolase--polymorphism and role in toxicology.

C J Omiecinski1, C Hassett, V Hosagrahara.   

Abstract

Microsomal epoxide hydrolase is a critical biotransformation enzyme that catalyzes the conversion of a broad array of xenobiotic epoxide substrates to more polar diol metabolites. The gene has been shown previously to exhibit polymorphism, including variation in the coding region leading to amino acid substitutions at positions 113 (Y/H) and 139 (H/R). To better evaluate the phenotype associated with the structural region genetic polymorphisms associated with mEH, we performed enzymatic analyses using purified mEH proteins that were expressed using a baculovirus system, or with microsomal preparations obtained from liver tissues that were derived from individuals with homozygous mEH allelic status. Benzo[a]pyrene-4, 5-oxide and cis-stilbene oxide were employed as substrates for the enzymatic determinations. Results obtained with the purified enzymes suggested that the reaction velocity catalyzed by the wild type (Y113/H139) protein was approximately two-fold greater than the corresponding velocities for the variant forms of the enzyme. However, when reaction rates were analyzed using human liver microsomal preparations, the maximal velocities generated among the variant mEH proteins were not statistically different. Collectively, these results indicate that the structural differences coded by the mEH genetic variants may have only modest impact on the enzyme's specific activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720753     DOI: 10.1016/s0378-4274(99)00235-0

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  22 in total

Review 1.  System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.

Authors:  Zhi-Qiang Zhao; Qing-Kai Guan; Fei-Yun Yang; Peng Zhao; Bing Zhou; Zhi-Jun Chen
Journal:  Tumour Biol       Date:  2011-12-13

2.  Sp1 and Sp3 transcription factors regulate the basal expression of human microsomal epoxide hydrolase (EPHX1) through interaction with the E1b far upstream promoter.

Authors:  Shengzhong Su; Curtis J Omiecinski
Journal:  Gene       Date:  2013-12-04       Impact factor: 3.688

3.  Smoking, the xenobiotic pathway, and clubfoot.

Authors:  Amy Sommer; Susan H Blanton; Katelyn Weymouth; Christine Alvarez; B Stephen Richards; Douglas Barnes; Jacqueline T Hecht
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-12-01

4.  Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.

Authors:  Marianne Samir Makboul Issac; Maggie S El-Nahid; Marian Youssry Wissa
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

5.  Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India.

Authors:  Ujjala Ghoshal; Sushil Kumar; Virendra Jaiswal; Shweta Tripathi; Balraj Mittal; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2013-04-12

Review 6.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Tryptophan fluorescence quenching by enzyme inhibitors as a tool for enzyme active site structure investigation: epoxide hydrolase.

Authors:  Evgenia G Matveeva; Christophe Morisseau; Marvin H Goodrow; Chris Mullin; Bruce D Hammock
Journal:  Curr Pharm Biotechnol       Date:  2009-09-01       Impact factor: 2.837

8.  Effect of CYP2E1 gene deletion in mice on expression of microsomal epoxide hydrolase in response to VCD exposure.

Authors:  Aileen F Keating; Kathila S Rajapaksa; I Glenn Sipes; Patricia B Hoyer
Journal:  Toxicol Sci       Date:  2008-07-12       Impact factor: 4.849

9.  Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.

Authors:  B G M Durie; B Van Ness; C Ramos; O Stephens; M Haznadar; A Hoering; J Haessler; M S Katz; G R Mundy; R A Kyle; G J Morgan; J Crowley; B Barlogie; J Shaughnessy
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

10.  Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.

Authors:  Nur Duale; Thomas Bjellaas; Jan Alexander; Georg Becher; Margaretha Haugen; Jan Erik Paulsen; Henrik Frandsen; Pelle Thonning Olesen; Gunnar Brunborg
Journal:  Toxicol Sci       Date:  2009-01-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.